Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus with EC-MPS vs Cyclosporine in Renal Transplant Maintenance
NCT00425308Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2006
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in kidney transplant rejection, sponsored by Novartis. Started Oct 2006; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00425308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425308.